Skip to content

Clinical trials

Withdrawn Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Status: Withdrawn Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20141
20162
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology1
Celgene1
Fred Hutchinson Cancer Center1
Gilead Sciences1
Indiana University1
M.D. Anderson Cancer Center1
Masonic Cancer Center, University of Minnesota1
Mayo Clinic1
Naoyuki G. Saito, M.D., Ph.D.1
Princess Maxima Center for Pediatric Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma11
Leukemia, Myeloid, Acute7
Leukemia6
Leukemia, Lymphocytic, Chronic, B-Cell6
Myelodysplastic Syndromes6
Burkitt Lymphoma5
Lymphoma, B-Cell, Marginal Zone5
Lymphoma, Follicular5
Lymphoma, Mantle-Cell5
Lymphoma, Non-Hodgkin5

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.